Middle East & Africa Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services ; Disease Indication ; and End User

Description

List of Tables

The Middle East & Africa bioanalytical testing services market was valued at US$ 221.87 million in 2022 and is expected to reach US$ 435.80 million by 2030; it is estimated to grow at a CAGR of 8.8% from 2022 to 2030.

Rising Drug Discovery and Development Activities for Emerging and Rare Diseases Fuel the Middle East & Africa Bioanalytical Testing Services Market

Bioanalytical testing services are used for the quantitative estimation of drugs and their metabolites in biological fluids. This testing is performed in the early stages of the drug development. Various biotechnology companies are engaging in collaborations to accelerate R&D activities and scale them up on a global level. Several ongoing drug research studies have shown positive outcomes for effectively treating chronic disorders such as cancer, neurological disorders, and autoimmune disorders. An upsurge in the prevalence of such disorders, coupled with the increase in R&D activities, would create demand for bioanalytical testing services in the coming years. An increase in the incidence of rare disorders such as amyloidosis, adrenoleukodystrophy, and Ehlers-Danlos syndrome has further bolstered the R&D activities for the development of interventions against them, which has been generating the demand for specific bioanalytical testing services. According to the Food and Drug Administration (FDA), in 2022, the Center for Drug Evaluation and Research (CDER) approved 37 novel drugs. Out of 37, 20 drugs were approved for rare diseases. Thus, the continuous efforts of drug companies to discover and develop drugs against rare and emerging diseases are expected to provide lucrative opportunities for the expansion of the bioanalytical testing service businesses during the forecast period.

Middle East & Africa Bioanalytical Testing Services Market Overview

The Middle East & Africa bioanalytical testing services market is segmented into UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Government initiatives to strengthen analytical testing capacities and growing number of drug approvals and clinical trials are catalyzing the bioanalytical testing services market in the Middle East & Africa. The increasing use and development of numerous macromolecules and biosimilars for various therapeutic areas and increased government spending to set up new laboratories are other factors accelerating the bioanalytical testing services market growth.

Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Bioanalytical Testing Services Market Segmentation

The Middle East & Africa bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the Middle East & Africa bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the Middle East & Africa bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the Middle East & Africa bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the Middle East & Africa bioanalytical testing services market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the Middle East & Africa bioanalytical testing services market.

Product Code: BMIRE00029561

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Bioanalytical Testing Services Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Middle East & Africa PEST Analysis

5. Middle East & Africa Bioanalytical Testing Services Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
- 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
5.2 Key Market Restraints:
- 5.2.1 High Cost Associated to Bioanalytical Testing Services
5.3 Key Market Opportunities
- 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
5.4 Future Trends
- 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - Middle East & Africa Market Analysis

6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Middle East & Africa Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

7.1 Overview
7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
7.3 Pharmacokinetics
- 7.3.1 Overview
- 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biomarkers
- 7.4.1 Overview
- 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Immunogenicity
- 7.5.1 Overview
- 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Virology Testing
- 7.6.1 Overview
- 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.6.2.1 In-Vitro Virology Testing
    - 7.6.2.1.1 Overview
  - 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
- 7.6.3 In-Vivo Virology Testing
  - 7.6.3.1 Overview
  - 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Cell-Based Assays
- 7.7.1 Overview
- 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

8.1 Overview
8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
8.3 Cardiovascular
- 8.3.1 Overview
- 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Neurological Diseases
- 8.4.1 Overview
- 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Autoimmune Disorders
- 8.5.1 Overview
- 8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Respiratory Diseases
- 8.6.1 Overview
- 8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Metabolic Disorders
- 8.7.1 Overview
- 8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Oncology
- 8.8.1 Overview
- 8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Sexual Health
- 8.9.1 Overview
- 8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Bone Disease
- 8.10.1 Overview
- 8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Others
- 8.11.1 Overview
- 8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Pharmaceutical and Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization (CRO)
- 9.4.1 Overview
- 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Development And Manufacturing Organization (CDMO)
- 9.5.1 Overview
- 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Bioanalytical Testing Services Market - Country Analysis

10.1 Middle East & Africa Bioanalytical Testing Services Market, Revenue and Forecast to 2030
- 10.1.1 Overview
  - 10.1.1.1 Middle East & Africa Bioanalytical Testing Services Market by Country
  - 10.1.1.2 UAE
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.2.3 UAE Bioanalytical Testing Services Market, by Services
    - 10.1.1.2.3.1 UAE Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.2.4 UAE Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.2.5 UAE Bioanalytical Testing Services Market, by End User
  - 10.1.1.3 Saudi Arabia
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.3.3 Saudi Arabia Bioanalytical Testing Services Market, by Services
    - 10.1.1.3.3.1 Saudi Arabia Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.3.4 Saudi Arabia Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.3.5 Saudi Arabia Bioanalytical Testing Services Market, by End User
  - 10.1.1.4 South Africa
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.4.3 South Africa Bioanalytical Testing Services Market, by Services
    - 10.1.1.4.3.1 South Africa Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.4.4 South Africa Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.4.5 South Africa Bioanalytical Testing Services Market, by End User
  - 10.1.1.5 Rest of Middle East & Africa
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.5.3 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Services
    - 10.1.1.5.3.1 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.1.5.4 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.1.5.5 Rest of Middle East & Africa Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioanalytical Testing Services Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 SGS SA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Pharmaron Beijing Co Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Element Materials Technology Group Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Eurofins Scientific SE
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Labcorp Drug Development Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Syneos Health Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 ICON Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Intertek Group Plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms